Analysis of the immune response to Fendrix as compared to double-dose Engerix B in HIV-infected non-responders to standard Hepatitis B vaccination courses
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2017
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 08 Feb 2017 Last checked against European Clinical Trials Database record.
- 08 Feb 2017 Planned number of patients changed from 30 to 10.
- 25 Oct 2015 Accrual to date is 3% according to United Kingdom Clinical Research Network record.